Cresco Labs Inc CRLBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRLBF is a good fit for your portfolio.
News
-
Cannabis rescheduling comment period ends with nearly 43,000 submissions
-
IRS leaves no wiggle room on higher taxes for legal cannabis companies
-
Cannabis company Columbia Care to cut costs and sell its Florida business
-
Cannabis stocks rise as U.S. moves to reclassify pot as less dangerous
-
U.S. cannabis-dispensary operator Cresco Labs posts narrower loss as revenue dips
-
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results
-
Nasdaq finally 'warming up' to Canadian cannabis companies with U.S. exposure. Could American growers be next?
-
Cannabis stocks pull back after rallying on DEA's plans to reclassify marijuana
Trading Information
- Previous Close Price
- $1.57
- Day Range
- $1.56–1.65
- 52-Week Range
- $1.00–2.77
- Bid/Ask
- $1.60 / $1.76
- Market Cap
- $561.79 Mil
- Volume/Avg
- 403,584 / 822,516
Key Statistics
- Price/Earnings (Normalized)
- 50.64
- Price/Sales
- 0.70
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,800
- Website
- https://www.crescolabs.com
Comparables
Valuation
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Price/Earnings (Normalized) | 50.64 | — | — |
Price/Book Value | 1.09 | 1.12 | 2.98 |
Price/Sales | 0.70 | 1.49 | 2.21 |
Price/Cash Flow | 5.81 | 11.51 | 46.08 |
Price/Earnings
CRLBF
VRNO
CURA
Financial Strength
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Quick Ratio | 0.83 | 0.57 | 0.29 |
Current Ratio | 1.36 | 1.01 | 0.72 |
Interest Coverage | −0.95 | 1.26 | −0.31 |
Quick Ratio
CRLBF
VRNO
CURA
Profitability
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Return on Assets (Normalized) | −4.46% | −2.26% | −5.56% |
Return on Equity (Normalized) | −11.60% | −4.10% | −16.04% |
Return on Invested Capital (Normalized) | −2.45% | −0.97% | −5.52% |
Return on Assets
CRLBF
VRNO
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jyswjklvz | Ymvy | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Kdvslmwmm | Lknck | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Qnrpqnfg | Lpnz | $41.4 Bil | |||
| Viatris Inc
VTRS
| Ltygzdt | Zvln | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Hcpssyp | Twv | $13.7 Bil | |||
| Catalent Inc
CTLT
| Jmmmyvqv | Cwbqflt | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Rprtysk | Ywdhm | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ndmysrpv | Mgvsx | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tpxjcznd | Wkcq | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Vwfnsmln | Tfnj | $2.7 Bil |